Other evidence supporting the importance of GSK3α on PDA, reported by Bang et al. [44], shows that GSK3α, but not GSK3β, regulates the non-canonical NF-κB activity by promoting the processing of p100 to p52 in the nucleus. The gene discussed is NFKB1; the disease is Patent ductus arteriosus.